Month: February 2021

WARSAW, Ind., Feb. 18, 2021 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics and which has expanded its operating reach over the last year to serve more children around the world, today announced the launch of APIFIX.COM, a new online presence aimed at informing patients, families and healthcare providers of a viable new alternative for the treatment of progressive adolescent idiopathic scoliosis (AIS).“Growing our online presence is one of many ways we are elevating the importance of offering a viable new option for patients and surgeons to consider when treating adolescent idiopathic scoliosis,” said Ryan Bledsoe, Director of Product Management at OrthoPediatrics. “The new website includes actionable information...

WILMINGTON, Del., Feb. 18, 2021 (GLOBE NEWSWIRE) — InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced results for the fourth quarter and full year ended December 31, 2020.Fourth Quarter 2020 Financial HighlightsRecurring revenue was $89.1 million, compared to $77.5 million in fourth quarter 2019, a 15% year-over-year increase, which was driven by six new patent license agreements signed during 2020. Total revenue was $90.8 million, compared to $102.2 million in fourth quarter 2019, which is attributable to past sales from deals signed in fourth quarter 2019.Operating expenses were $87.7 million, compared to $76.9 million in fourth quarter 2019, due to one-time charges of approximately $10.0 million, primarily related to a non-cash charge for on-going patent portfolio...

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 PM Pacific Time/5:00 PM Eastern Time.Audio WebcastThe webcast will be made available on the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following the live audio webcast, a replay will be available on the Company’s website for approximately 30 days.Dial-In InformationLive (U.S. / Canada): 1 (866) 940-5062Live (International):...

ISLAND PARK, N.Y., Feb. 18, 2021 (GLOBE NEWSWIRE) — Global Diversified Marketing Group Inc (OTC: GDMK) reported results for its fiscal year ended December 31st, 2020.Financial highlights for the full year ended December 31st, 2020, compared to the full year ended December 31st, 2019, were as follows:Revenue increased to $1,660,726 compared to $1,317,092, an increase of 26.1% over 2019 periodGross profit margin improved to 39.8% in 2020 compared to 28.2% in 2019.  The net loss for the year ended December 31st, 2020, includes a one-time, non-cash, non-operating charge of $26,020,400 for stock-based compensation expense relating to the issuance of super-voting preferred stock to the Company’s Chief Executive Officer and $168,529 in stock-based compensation to consultants. Excluding those charges, the Company’s Adjusted Net Profit (Loss)...

SAN FRANCISCO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE:DLB) today announced that Lewis Chew, Executive Vice President and Chief Financial Officer, Dolby Laboratories, will present at the Morgan Stanley 2021 Technology, Media, and Telecom Conference to be held virtually on Thursday, March 4, 2021, at 5:00 p.m. ET (2:00 p.m. PT).A live webcast and replay of the presentation will be available at http://investor.dolby.com.About Dolby LaboratoriesDolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. We partner with artists, storytellers, developers, and businesses to revolutionize entertainment and...

NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading provider of Life and Annuity software, enables insurance carriers to prepare for tomorrow’s challenges with the launch of LifePRO® 20, an innovative digital policy administration platform.LifePRO® 20 is a powerful end-to-end digital solution that supports the entire insurance policy administration lifecycle – from new business to claim – for an extensive array of individual, worksite and group life, health, and annuity products. LifePRO 20 enables companies to quickly bring new products to market, fuel growth and manage operations to drive down cost.The power of LifePRO® can be extended even further when paired with LDS, EXL’s new business and underwriting module providing a fully integrated “digital platform in a box” from new business to claims.Improve business...

The Nomination Committee of Bilia AB submits the following proposals to be presented at the Annual General Meeting of shareholders to be held on April 27, 2021, regarding number of members of the Board and election of members of the Board.The Nomination Committee proposes nine members of the Board with no deputy members.The Nomination Committee proposes re-election of the Board including the following persons: Gunnar Blomkvist, Anna Engebretsen, Eva Eriksson, Mats Holgerson, Ingrid Jonasson Blank, Nicklas Paulson, Jan Pettersson, Mats Qviberg and Jon Risfelt.The Nomination Committee proposes Mats Qviberg to be re-elected as chairman of the Board.The members of the Nomination Committee are Tim Floderus (Investment AB Öresund, chairman), Mats Qviberg (the Qviberg family), Lisen Oliw (Anna Engebretsen and family) and Suzanne Sandler (Handelsbanken...

Valberedningen för Bilia AB lägger fram följande förslag till beslut på årsstämman den 27 april 2021 avseende antal styrelseledamöter och val av styrelseledamöter.Valberedningen föreslår nio ordinarie styrelseledamöter utan suppleanter.Valberedningen föreslår omval av hela styrelsen bestående av Gunnar Blomkvist, Anna Engebretsen, Eva Eriksson, Mats Holgerson, Ingrid Jonasson Blank, Nicklas Paulson, Jan Pettersson, Mats Qviberg och Jon Risfelt.Valberedningen föreslår omval av Mats Qviberg till styrelsens ordförande.Valberedningen består av Tim Floderus (Investment AB Öresund, ordförande), Mats Qviberg (familjen Qviberg), Lisen Oliw (Anna Engebretsen med familj) och Suzanne Sandler (Handelsbanken Fonder).                     Information om de till omval föreslagna ledamöterna finns på Bilia AB:s hemsida. Valberedningens övriga förslag...

Englewood Cliffs, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders, announced today that it has finalized its previously announced agreement to license an innovative Central nervous system-homing peptides for treatment of multiple sclerosis and other neuroinflammatory pathology, signing a  Master License Agreement with the University of Maryland Baltimore.Researchers at the University discovered this novel peptide and have completed preclinical studies supporting its efficacy.  Mr. Eric Weisblum, Chief Executive Officer of Silo Pharma, commented, “Silo Pharma is committed to innovation,...

Revenue of $39.7 million for the year and $12.2 million for the 4thquarter; Adj. EBITDA of approximately $6.5 million for the year and a record $2.5 million for the quarterBEVERLY, Mass. and TORONTO, Feb. 18, 2021 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported preliminary selected unaudited financial results for the fourth quarter and year ended December 31, 2020.Based on preliminary unaudited results, 2020 revenues increased 12% to a record $39.7 million with adjusted EBITDA for the year of approximately $6.5 million, an 8% decline versus the prior year. Fourth quarter sales increased 13% to $12.2 million, with adjusted EBITDA estimated to...